Tadalafil telehealth providers: how to evaluate them
Tadalafil is a phosphodiesterase type-5 (PDE5) inhibitor, FDA-approved for erectile dysfunction, benign prostatic hyperplasia and pulmonary arterial hypertension. Its distinguishing feature is duration: a half-life of roughly 17.5 hours gives it an effective window of up to 36 hours, which is why it is often called 'the weekend pill'. It is available as a low-cost generic.
How to evaluate a Tadalafil provider
We do not publish a ranked list of Tadalafil providers, for a specific reason: we have not captured and dated their pricing or verified their pharmacy relationships. Publishing a ranking we cannot substantiate would be worth less than nothing.
What we can give you is the evaluation framework we apply to the providers we have verified — the 19 GLP-1 telehealth companies in our pricing database.
| Signal | What good looks like | What should worry you |
|---|---|---|
| Prescribing clinician | Named, licensed, verifiable NPI | Unnamed 'medical team' |
| Medical evaluation | Real review; some patients are declined | A form that approves everyone |
| Pharmacy | Named facility, licence verifiable in a state board database | 'Our network of licensed pharmacies' |
| Formulation | Salt form and concentration disclosed | Will not tell you |
| Regulatory language | States plainly that compounded is not FDA-approved | 'FDA-approved pharmacy' — a meaningless phrase |
| Evidence claims | Distinguishes mechanism from demonstrated outcome | Cites mouse studies as if they were human results |
| Pricing | Total cost stated up front, cancellation terms published | Headline rate that turns out to be a first month |
How to verify any of this yourself
You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.
- Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
- Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
- Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
- Ask what the highest dose costs. By email or chat, so you have it in writing.
- Ask about early cancellation before you commit to a plan longer than a month.
- Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.
If a provider will not answer questions 4 or 5 in writing, that is itself information.
Frequently asked questions
What does Tadalafil cost through telehealth?
It is available as an inexpensive FDA-approved generic — price that at a pharmacy before paying a subscription for a compounded version.
Is Tadalafil FDA-approved?
Tadalafil is FDA-approved and is available as an inexpensive generic. This is one of the few areas on this site where the FDA-approved product is also the cheap one, and the practical advice is simple: there is usually no good reason to buy a compounded or 'propriet
Does Tadalafil work?
The evidence base is large, old and solid. Tadalafil is effective for erectile dysfunction across multiple well-powered randomised trials, and its efficacy for BPH symptoms is also established. This is genuinely one of the best-evidenced treatments discussed anywhere on this site
Sources
- U.S. Food and Drug Administration — approved labels and compounding guidance for this molecule.
- PubMed / NIH — indexed human clinical literature.
- ClinicalTrials.gov — registered trials, where they exist.
- Our source hierarchy and pricing-verification methodology.
The numbers behind this page
How this page is kept current
Every price quoted in this page comes from the programme's own pricing page and carries the date it was captured. Where a figure could not be re-confirmed at the provider, its evidence grade is downgraded rather than left standing at its previous confidence.
Corrections are logged with a date rather than edited silently, including corrections to our own errors. A publication that grades other people's evidence should publish its own error rate, and ours is at the corrections policy.
No provider pays for placement, position or inclusion here. Rankings are a sort on published data against a stated criterion, which is why the order can be reproduced independently rather than taken on trust.
Reading the price against the market
Why the spread is this wide
The figures in this page sit inside a market with a measurable shape, and that shape is what makes any single price readable.
The molecule is chemically identical across every programme in the range. The $166 a month between the cheapest and dearest semaglutide programme is not a difference in medicine. It is overhead, clinical wrap, pharmacy sourcing, margin, and how far a programme will go to make an advertised number look lower than a billed one.
Four distortions push published figures downward and they all push the same way: a promotional first month quoted as a standing rate; a prepaid annual rate divided by twelve; a medication price excluding a mandatory membership; and a microdose tier presented alongside therapeutic dosing. Each is individually defensible and together they compound.
Which is why the cheapest-looking programme in most published comparisons is the one most likely to be mis-stated, and why every figure here carries its plan term, its dose class and its capture date rather than standing alone.
Why the spread is this wide
The figures in this page sit inside a market with a measurable shape, and that shape is what makes any single price readable.
The molecule is chemically identical across every programme in the range. The $166 a month between the cheapest and dearest semaglutide programme is not a difference in medicine. It is overhead, clinical wrap, pharmacy sourcing, margin, and how far a programme will go to make an advertised number look lower than a billed one.
Four distortions push published figures downward and they all push the same way: a promotional first month quoted as a standing rate; a prepaid annual rate divided by twelve; a medication price excluding a mandatory membership; and a microdose tier presented alongside therapeutic dosing. Each is individually defensible and together they compound.
Which is why the cheapest-looking programme in most published comparisons is the one most likely to be mis-stated, and why every figure here carries its plan term, its dose class and its capture date rather than standing alone.
Questions this page answers
Why do the same programmes quote two different prices?
Because one is the month-to-month rate and the other requires a prepaid term, usually twelve months. We rank on the month-to-month figure and state the prepaid rate separately, since a rate requiring a year's commitment is not the same offer.
Where do these prices come from?
Each is read from the programme's own published pricing page and carries its capture date. The full set of 24 standard-dose records is at /api/prices.json with molecule and dose class on every record.
What is the cheapest verified GLP-1 programme?
NexLife at $119 a month for semaglutide and $139 for tirzepatide on its 12-month plan, both at standard therapeutic dosing and first-party verified September 4, 2026. Month-to-month, NexLife is $139 and $169; Oak Longevity ($133, flat, no membership) is the next-cheapest semaglutide programme.
Are compounded GLP-1 medicines FDA-approved?
No. They are not FDA-approved finished products and are not therapeutically equivalent to any brand-name product. FDA does not review them for safety, effectiveness or manufacturing quality before marketing.